Seroprevalence of antibodies against SARS-Cov-2 among adults from a municipality in the Buenos Aires suburbs, República Argentina
Authors:
- Ezequiel ConsiglioECEzequiel Consiglio
- Carlos FreytesCFCarlos Freytes
- Leandro FacalLFLeandro Facal
- María José Dus SantosMSMaría José Dus Santos
- Magdalena Radgtky CafferaMCMagdalena Radgtky Caffera
- Marina MozgovojMarina Mozgovoj
- Iris Celeste RobledoIRIris Celeste Robledo
- Marcela PilloffMPMarcela Pilloff
- Adriana Fernandez SoutoASAdriana Fernandez Souto
- Juan PedrosaJPJuan Pedrosa
Open Access
- 30 June 2023
- journal article
- research article
- Published by Universidad de Costa Rica in Población y Salud en Mesoamérica
- Vol. 21 (1)
Abstract
The objective of this study was to determine the prevalence of anti-bodies against SARS-CoV-2. Between November twenty-one and December twelve of two thousand and twenty year, a cross-sectional study was carried out in 1182 samples from residents of a Buenos Aires town in the Province of Buenos Aires, Argentina. IgG was measured by ELISA in samples obtained by acupressure. The global prevalence was 12.2 % (n = 144; 95 % CI: 10.3 - 14.0) with a ratio of 1: 3.8, between cumulative incidence and observational values. Prevalence in women and men were 13.0 % (95 % CI: 10.2 - 15.7) and 10.5 % (95 % CI: 7.6 - 13.3), respectively (p = 0.21). By age, the observed values were: 17.8 % (95 % CI: 12.0 - 23.6) in 18 and 30 years old group; 12.2 % (95 % CI: 9.3 - 15.1) in 31 to 60 years old group, 9.9 % (95 % CI: 6.9 - 13.9) in people over 61 years old (p = 0.02). According the socioeconomic tertiles (for Unsatisfied Basic Needs) the prevalence values were 7.7 % (95 % CI: 4.7 - 10.7) for Tertile I (best tertile), 12.5 % (95 % CI: 8.7 - 16.4) for Tertile II, and 15.2 % (95 % CI: 11.6 - 18.8) for Tertile III (p = 0.002). There were also differences between the neighbourhoods and between self-reported clinical variables. Specific IgM antibodies were detected in 12 samples, which represented 1% of the total. Seroprevalence studies provide useful information that can be apllied to fit modeling.Keywords
This publication has 34 references indexed in Scilit:
- Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurveyThe Lancet Regional Health - Americas, 2022
- Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in SpainJournal of Clinical Virology, 2022
- Update on SARS-CoV-2 seroprevalence: regional and worldwideClinical Microbiology and Infection, 2021
- SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, PerueClinicalMedicine, 2021
- SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysisClinical Microbiology and Infection, 2021
- A systematic review of asymptomatic infections with COVID-19Journal of Microbiology, Immunology and Infection, 2021
- How SARS-CoV-2 (COVID-19) spreads within infected hosts — what we know so farEmerging Topics in Life Sciences, 2020
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020JAMA Internal Medicine, 2020
- SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveysThe Lancet Global Health, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020